Loading
Life sciences · Journal article
Advanced Science · September 27, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT Triple‐negative breast cancer (TNBC) is an aggressive subtype characterized by poor prognosis because of a lack of effective therapeutic agents. Changes in extracellular matrix (ECM) composition, particularly type I collagen density, significantly influence crucial cellular activities. However, the association between type I collagen density and TNBC progression remains unclear. This study finds that type I collagen density and mechanical characteristics of lesions predict the pathological grade and malignant progression of TNBC patients. The results of transcriptomics and metabolomics studies suggest that high‐density type I collagen promotes TNBC ferroptosis. Further in vitro experiments indicate that high‐density type I collagen promotes ferroptosis in TNBC cells through spermidine/spermine N1‐acetyltransferase 1 (SAT1)/argininosuccinate synthase (ASS1)‐induced glutamine (Gln) accumulation. Moreover, in vitro co‐culture and in vivo experiments reveal that high‐density type I collagen increases the uptake of Gln in TNBC cells, leading to Gln deprivation of IFN‐γ + CD8 + T cells in the tumor microenvironment, resulting in higher level of immunosuppression. Combination of ferrostatin 1 and anti‐PD‐1 therapy reverses high‐density collagen‐induced tumor progression of TNBC. The clinical samples further verify the role of collagen density in TNBC. This study reveals that high‐density type I collagen participates in TNBC progression partly through immunosuppression induced by Gln accumulation‐related ferroptosis.